[1]
“CASE REPORT ON RENAL ANGIOMYOLIPOMA”, Journal of Pharmaceutical Negative Results, vol. 13, no. 3, pp. 912–914, Oct. 2022, doi: 10.47750/pnr.2022.13.03.137.